Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy S Tse

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|May 11, 2017
Octreotide-Associated NeutropeniaStacy S Tse, Troy Kish
Current Pharmaceutical Design|March 9, 2019
Novel Targets For Therapeutic Intervention in Inflammatory Bowel Disease. What is the Best Way to Assess the Safety Profile of a Drug?Clara Yzet, Stacy S Tse, Maia Kayal, et al.
Inflammatory Bowel Diseases|January 3, 2022
Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces ImmunogenicityMarla C Dubinsky, Michelle L Mendiolaza, Becky L Phan, et al.
Inflammatory Bowel Diseases|August 31, 2023
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA ConsensusShubha Bhat, Ruishen Lyu, Mitali Agarwal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|May 11, 2017
Octreotide-Associated NeutropeniaStacy S Tse, Troy Kish
Current Pharmaceutical Design|March 9, 2019
Novel Targets For Therapeutic Intervention in Inflammatory Bowel Disease. What is the Best Way to Assess the Safety Profile of a Drug?Clara Yzet, Stacy S Tse, Maia Kayal, et al.
Inflammatory Bowel Diseases|January 3, 2022
Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces ImmunogenicityMarla C Dubinsky, Michelle L Mendiolaza, Becky L Phan, et al.
Inflammatory Bowel Diseases|August 31, 2023
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA ConsensusShubha Bhat, Ruishen Lyu, Mitali Agarwal, et al.
Pageof 1